It is always debated when to fade these hike cycles. I myself tend to panic when the rates are going up but the exact time to pull in the reigns is at the 1st lowering of rates.
GBA Presents: House of Gummy-!
- Thread starter stonedinvestor
- Start date
Stoney this is quite unlike the gentle gummy infusion speech you are known for. You are usually more kind, no drinking hard booze, only Sativa Tilray.
The readers are all well aware that Stoney's daily posting routine (and the demeanor thereof regarding said posts) is strongly correlated to the time of day he is posting. Highly predictable. That's exactly why I know how and when to push his buttons----> when he is getting out of line of course.
There is still one countenance of his personality that is difficult to understand.... and that is.... why it is so hard for him to accept someone that gets the bigger picture macro calls right time and time again.
In our little microcosm here, that would of course would be in reference to me and the near/long term levels of the S&P. But, I am afraid this goes deeper. To be in complete denial that someone else has outshined him quarter after quarter (for example someone calling the June/July/and possibly the 1st half of August SPX to T the while all along he has been screaming for a correction at every level higher week after week).... this is an area of concern. It's complete denial of reality.
But here is what the really strange thing is... he claims his calls were right.
This of course is why VZ is a strong proponent of NOT legalizing weed nationwide. Not so much for Stoney... but for the children. They are already dumbed down enough. If Stoney can say he is a great SPX market timer after his track record over the last 12 months here.... that is brain damage. Imagine what that sh*t can do to a developing brain. I've said it a dozen times on ET... weed makes folks delusional. Good for music, good for art.... good for a lot of things really. But science and math aren't part of that category.
A $43 stock dropping to $28 in a few months.
Yeah I know.... but just slide the decimal point left a little... it's same thing.
OUCH.
I actually stumbled on this one looking for something else.
Lol....
this is the one I was looking for... from waaay back in April.
Seriously Stoney.... you need to get out in the real world more.
I will say this however.... the realtor "for sale" signs in people's front yards, seem to be staying up significantly longer. That will provide downward pressure on home prices in the aggregate.
BUT WRITE THIS DOWN STONEY BECAUSE IT'S A BIGGIE.....
As I always say.... the so-called experts are severely adhd'd.
Like most of the stuff I share here.... in a month or so it'll become common knowledge.
When the Fed looks at the CPI in Sept.... that is a 12 month moving window. That means July/August of 2022 housing prices fall off the average. And those two months were a peak. In any major city at least. That means the part of the CPI that actually includes housing... is gonna show a nice drop.
Of course the real experts know this already.... but here's the bottom line. There is not gonna be another hike in Sept. despite what many are saying. That's why the markets continue to rally... the cnbc folks talk of a hike.... the whales chuckle because they know it ain't gonna happen.
Write that down too Stoney.
We’ve said it before, losing $100,000 to Stoney means, ten less pairs of shoes. Vintage Stoney pic below.A $43 stock dropping to $28 in a few months.
Yeah I know.... but just slide the decimal point left a little... it's same thing.
OUCH.
I actually stumbled on this one looking for something else.
Good Morning Stock Fans-- I would of preferred the exact open we are going to have to the downside and then a reverse up.../ Looks like a near flat open.
Broadwind reaffirms FY23 revenue $205M-$220M, consensus $211.58M » 07:04
BWEN Sees non-GAAP adjusted… Broadwind reports Q2 EPS 7c, consensus 0c » 07:04 BWEN
Amylyx (Nasdaq: AMLX) started selling the ALS drug, Relyvrio, in the U.S. in late 2022. Shortly after, the company turned a $1.6 million profit for the first quarter of 2023. In the second quarter, reported by the company last week, Amylyx increased that nearly 14-fold, posting a $22.1 million profit, all driven by Relyvrio sales.
Broadwind reaffirms FY23 revenue $205M-$220M, consensus $211.58M » 07:04
BWEN Sees non-GAAP adjusted… Broadwind reports Q2 EPS 7c, consensus 0c » 07:04 BWEN
Amylyx (Nasdaq: AMLX) started selling the ALS drug, Relyvrio, in the U.S. in late 2022. Shortly after, the company turned a $1.6 million profit for the first quarter of 2023. In the second quarter, reported by the company last week, Amylyx increased that nearly 14-fold, posting a $22.1 million profit, all driven by Relyvrio sales.
--U.S. Steel Stock Soars. It’s Exploring Options After Rejecting Cleveland-Cliffs Bid.
STLD? Normally this would be my go-to here... but CMC is my name>
->Commercial Metals Company (CMC)@$55-
NYSE - NYSE Delayed Price.
55.05+0.09(+0.16%)
At close: August 11 04:00PM EDT
STLD? Normally this would be my go-to here... but CMC is my name>
->Commercial Metals Company (CMC)@$55-
NYSE - NYSE Delayed Price.
55.05+0.09(+0.16%)
At close: August 11 04:00PM EDT
2nd Idea->
Carpenter Technology Corporation (CRS)@$57.50
NYSE - NYSE Delayed Price.
57.53-0.05(-0.09%)
At close: August 1
Carpenter Technology Corporation (CRS)@$57.50
NYSE - NYSE Delayed Price.
57.53-0.05(-0.09%)
At close: August 1